Add BrightSurf on Google Email

Mary Ann Liebert, Inc./Genetic Engineering News


Alternative and complementary medicine should have role in new era of health care reform

The article highlights the importance of alternative and complementary medicine (CAM) in healthcare reform, advocating for universal coverage and evidence-based methods. CAM encourages a holistic view of health, promoting whole-systems approaches and multifactorial integrative therapies.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalThe Journal of Alternative and Complementary Medicine·DateFeb 5, 2009

Newly described contaminant sources in Katrina-flooded homes pose health risks

A modeling study reveals that Katrina-flooded homes can harbor hazardous contaminants in the air, posing significant health risks to residents and first responders. The study identifies inhalation exposure routes through volatile and semi-volatile organic pollutants, highlighting the need for better preparation and safety protocols.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalEnvironmental Engineering Science·DateFeb 2, 2009

Blue light destroys antibiotic-resistant staph infection

Researchers have discovered that blue light can effectively destroy two common strains of methicillin-resistant Staphylococcus aureus (MRSA) in a laboratory setting. The study found that high-dose photo-irradiation using 470-nm blue light was able to kill up to 90.4% of the bacteria, making it a promising potential treatment for MRSA i...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPhotomedicine and Laser Surgery·DateJan 29, 2009

Medical acupuncture gaining acceptance by the US Air Force

The US Air Force is integrating medical acupuncture into its military healthcare, utilizing a technique developed by Dr. Richard Niemtzow to relieve severe pain lasting several days. This approach reduces reliance on pain medications that may cause adverse reactions or addiction, offering a promising alternative for pain management in ...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalMedical Acupuncture·DateDec 18, 2008

Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics

Biotech scientists are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates. This trend towards predictive toxicogenomics aims to develop a new compound's mechanism of action and predict toxicity, with several companies and consortia already working on this technology.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalGenetic Engineering & Biotechnology News·DateNov 19, 2008

Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics

Molecular diagnostic products are based on cutting-edge research in genomics and proteomics, enabling early detection of cancer and optimizing drug therapy. Companies like Roche, Myriad Genetics, and Genomic Health are well-positioned for future growth with their genetic tests and companion diagnostics.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalGenetic Engineering & Biotechnology News·DateOct 3, 2008

Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery

Researchers are developing novel hit-to-lead drug discovery strategies utilizing a combination of high-throughput screening, miniaturization, and advanced data analysis. This approach enables the identification of promising compounds with increased efficiency, leading to faster and more effective disease treatments.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalGenetic Engineering & Biotechnology News·DateJul 8, 2008

New report on telehealth says market is expected to grow over next few years

The home telehealth and remote patient monitoring market is projected to grow at a rate of 70% over the next three to five years, driven by increasing demand for convenient and accessible healthcare services. The combined average annual revenue growth of consumer companies in this market is even more explosive, reaching up to 193.5%.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalTelemedicine and e-Health·DateMay 22, 2008

Genetic Engineering & Biotechnology News reports on cancer biomarkers

Biotech companies are developing novel biomarkers to improve cancer diagnostic tests, potentially reducing treatment costs. Researchers at various institutions, including the Ludwig Institute for Cancer Research and Wayne State University School of Medicine, are working on early detection tools for malignancies.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalGenetic Engineering & Biotechnology News·DateApr 1, 2008

Umbilical cord blood cell therapy in an animal model of Alzheimer's disease

Researchers found that human umbilical cord blood cell therapy significantly reduced amyloid-β and β-amyloid plaques in mice with Alzheimer's-like disease. The treatment modulates the immune system by suppressing CD40-CD40L activity, offering potential for targeting inflammatory responses associated with degenerative conditions.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalStem Cells and Development·DateMar 26, 2008

Debate over safety of gene therapy trials focuses on issue of informed consent

A series of commentaries in Human Gene Therapy explores key controversies surrounding patient recruitment and trial management in gene therapy trials. The authors discuss the challenges of patients comprehending lengthy and technical study descriptions and consent forms, and propose innovative strategies for improving informed consent.